ATI RN
ATI Endocrine Pharmacology Quizlet Questions
Question 1 of 5
Which of the following drugs would be appropriate for local therapy in this patient?
Correct Answer: B
Rationale: The correct answer is B: Norgestrel. Norgestrel is a progestin used for local therapy in this patient because it can be administered directly to the affected area to target specific tissues. Ethinyl estradiol, Anastrozole, and Tamoxifen are not appropriate for local therapy as they are systemic drugs that act throughout the body. Ethinyl estradiol is an estrogen component in combined oral contraceptives, Anastrozole is an aromatase inhibitor used for breast cancer systemically, and Tamoxifen is a selective estrogen receptor modulator used for breast cancer treatment.
Question 2 of 5
A 21-year-old woman complained to her physician of recurrent nausea lasting most of the day. The woman had been suffering from a urinary tract infection presently being treated with ciprofloxacin and from gastroesophageal reflux disease presently being treated with omeprazole. She also routinely took ibuprofen during her menstrual period. One week ago, she started taking a contraceptive pill (ethinyl estradiol and norgestrel). Which of the following drugs most likely caused the patient's nausea?
Correct Answer: C
Rationale: The correct answer is C: Norgestrel. Nausea is a common side effect of contraceptive pills, especially when initially starting them. Norgestrel is a component of the contraceptive pill the patient started one week ago, which aligns with the timing of the onset of her nausea symptoms. Ciprofloxacin and omeprazole are less likely to cause nausea in this case, as the patient has been taking them for some time without issues. Ethinyl estradiol is also a component of the contraceptive pill but is less likely to be the primary cause of the nausea compared to norgestrel.
Question 3 of 5
Which of the following would be an appropriate change in the treatment plan for a patient with osteoporosis and hypertension experiencing a significant decrease in bone mass despite current therapy?
Correct Answer: C
Rationale: The correct answer is C: Add calcitonin to the current regimen. Calcitonin helps to increase bone density and reduce bone loss in osteoporosis. This would address the significant decrease in bone mass. Choice A (substitute hydrochlorothiazide with propranolol) is incorrect as propranolol does not have a direct impact on bone mass. Choice B (substitute raloxifene with ethinyl estradiol) is incorrect as ethinyl estradiol is not typically used for osteoporosis and may not be effective. Choice D (increase the daily dose of calcium carbonate) is incorrect as simply increasing calcium intake may not be sufficient to address the bone loss, especially in the presence of inadequate bone formation. Adding calcitonin addresses the root cause of bone loss in osteoporosis and is therefore the appropriate change in the treatment plan.
Question 4 of 5
Which one of the following compounds is not a hormone?
Correct Answer: A
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 5 of 5
Who is least likely to be treated with somatropin?
Correct Answer: A
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.